A polymorphism in metallothionein 1A (MT1A) is associated with cadmium-related excretion of urinary beta 2-microglobulin

Toxicology and Applied Pharmacology

Volumn 265, Issue 3, 2012, Pages 373-379

  Lei, Lijian ^a,b   Chang, Xiuli ^a   Rentschler, Gerda ^c   Tian, Liting ^a   Zhu, Guoying ^a   Chen, Xiao ^a   Jin, Taiyi ^a   Broberg, Karin ^c  

^a FUDAN UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Beta 2 microglobulin; Genetic polymorphism; Kidney; Metallothionein; Proteinuria

Indexed keywords

BETA 2 MICROGLOBULIN; CADMIUM; METALLOTHIONEIN; METALLOTHIONEIN 1A PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BETA 2 MICROGLOBULIN URINE LEVEL; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; CADMIUM POISONING; CHINA; CROSS-SECTIONAL STUDIES; DNA; ENVIRONMENTAL POLLUTANTS; FEMALE; GENOTYPE; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; METALLOTHIONEIN; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84870291620     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.09.006     Document Type: Article

References (31)

1. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 2000, 59:95-104.
2. Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 2004, 17:519-523.
3. Carrion A.M., Link W.A., Ledo F., Mellstrom B., Naranjo J.R. DREAM is a Ca2+-regulated transcriptional repressor. Nature 1999, 398:80-84.
4. Chaumont A., Nickmilder M., Dumont X., Lundh T., Skerfving S., Bernard A. Associations between proteins and heavy metals in urine at low environmental exposures: evidence of reverse causality. Toxicol. Lett. 2012, 210:345-352.
5. Donze D., Townes T.M., Bieker J.J. Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching. J. Biol. Chem. 1995, 270:1955-1959.
6. Giacconi R., Caruso C., Lio D., Muti E., Cipriano C., Costarelli L., Saba V., Gasparini N., Malavolta M., Mocchegiani E. CD14 C (-260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins. Int. J. Cardiol. 2007, 120:45-51.
7. Hare R.S. Endogenous creatinine in serum and urine. Proc. Soc. Exp. Biol. Med. 1950, 74:148-151.
8. Haslinger A., Karin M. Upstream promoter element of the human metallothionein-IIA gene can act like an enhancer element. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:8572-8576.
9. Järup L., Åkesson A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 2009, 238:201-208.
10. Jin T., Lu J., Nordberg M. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 1998, 19:529-535.
11. Jin T., Nordberg G., Wu X., Ye T., Kong Q., Wang Z., Zhuang F., Cai S. Urinary N-acetyl-beta-D-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ. Res. 1999, 81:167-173.
12. Jin T., Nordberg M., Frech W., Dumont X., Bernard A., Ye T.T., Kong Q., Wang Z., Li P., Lundstrom N.G., Li Y., Nordberg G.F. Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad). Biometals 2002, 15:397-410.
13. Kayaalti Z., Mergen G., Soylemezoglu T. Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from Turkish population. Toxicol. Appl. Pharmacol. 2010, 245:252-255.
14. Kayaalti Z., Aliyev V., Soylemezoglu T. The potential effect of metallothionein 2A-5A/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels. Toxicol. Appl. Pharmacol. 2011, 256:1-7.
15. Kita K., Miura N., Yoshida M., Yamazaki K., Ohkubo T., Imai Y., Naganuma A. Potential effect on cellular response to cadmium of a single-nucleotide A->G polymorphism in the promoter of the human gene for metallothionein IIA. Hum. Genet. 2006, 120:553-560.
16. Klaassen C.D., Liu J., Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu. Rev. Pharmacol. Toxicol. 1999, 39:267-294.
17. Li J., Liu Y., Ru B. Effect of metallothionein on cell viability and its interactions with cadmium and zinc in HEK293 cells. Cell Biol. Int. 2005, 29:843-848.
18. Liang Y., Lei L., Nilsson J., Li H., Nordberg M., Bernard A., Nordberg G.F., Bergdahl I.A., Jin T. Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas. Environ. Health Perspect. 2012, 120:223-228.
19. Liu J., Liu Y., Goyer R.A., Achanzar W., Waalkes M.P. Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol. Sci. 2000, 55:460-467.
20. Lu J., Jin T., Nordberg G., Nordberg M. Metallothionein gene expression in peripheral lymphocytes from cadmium-exposed workers. Cell Stress Chaperones 2001, 6:97-104.
21. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., Cipriano C., Powell J.R., Mocchegiani E. Effects of interleukin-6 -174C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageing. Exp. Gerontol. 2008, 43:423-432.
22. Mocchegiani E., Giacconi R., Malavolta M. Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol. Med. 2008, 14:419-428.
23. Nogawa K., Kido T., Yamada Y., Tsuritani I., Honda R., Ishizaki M., Terahata K. Alpha 1-microglobulin in urine as an indicator of renal tubular damage caused by environmental cadmium exposure. Toxicol. Lett. 1984, 22:63-68.
24. Nordberg G., Nordberg Monica, Friberg Lars T. Cadmium. Handbook on the Toxicology of Metals 2007, 445-486. Academic Press. B.A.F. Gunnar, F. Nordberg, M. Nordberg, L.T. Friberg (Eds.).
25. Nordberg G., Jin T., Wu X., Lu J., Chen L., Liang Y., Lei L., Hong F., Bergdahl I.A., Nordberg M. Kidney dysfunction and cadmium exposure - factors influencing dose-response relationships. J. Trace Elem. Med. Biol. 2012, 26:197-200.
26. Palmiter R.D., Sandgren E.P., Koeller D.M., Brinster R.L. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol. Cell. Biol. 1993, 13:5266-5275.
27. Price R.G. Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine methods and clinical applications. Eur. J. Clin. Chem. Clin. Biochem. 1992, 30:693-705.
28. Spicuglia S., Vincent-Fabert C., Benoukraf T., Tibéri G., Saurin A.J., Zacarias-Cabeza J., Grimwade D., Mills K., Calmels B., Bertucci F., Sieweke M., Ferrier P., Duprez E. Characterisation of genome-wide PLZF/RARA target genes. PLoS One 2011, 6:e24176.
29. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 2004, 96:434-442.
30. Wu X., Liang Y., Jin T., Ye T., Kong Q., Wang Z., Lei L., Bergdahl I.A., Nordberg G.F. Renal effects evolution in a Chinese population after reduction of cadmium exposure in rice. Environ. Res. 2008, 108:233-238.
31. Yang L., Li H., Yu T., Zhao H., Cherian M.G., Cai L., Liu Y. Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E987-E992.